Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 25, Pages 3305-3314
Publisher
Springer Nature
Online
2014-08-25
DOI
10.1038/onc.2014.261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The unconventional secretion of stress-inducible protein 1 by a heterogeneous population of extracellular vesicles
- (2013) Glaucia N. M. Hajj et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Comparison between Manual and Automated Evaluations of Tissue Microarray Patterns of Protein Expression
- (2013) Arthur W. Alvarenga et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
- (2013) Kyeung Min Joo et al. Cell Reports
- 1H, 15N and 13C backbone resonance assignments of the TPR1 and TPR2A domains of mouse STI1
- (2012) Andrzej Maciejewski et al. Biomolecular NMR Assignments
- Knockdown of Hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines
- (2012) Tarryn Willmer et al. CANCER LETTERS
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Endpoints for clinical trials and revised assessment in neuro-oncology
- (2012) Nicholas Butowski et al. CURRENT OPINION IN NEUROLOGY
- Dynamics of the regulation of Hsp90 by the co-chaperone Sti1
- (2012) Chung-Tien Lee et al. EMBO JOURNAL
- Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review
- (2012) Chip Caine et al. Expert Review of Anticancer Therapy
- Drug delivery strategies for the treatment of malignant gliomas
- (2012) Daniela Allhenn et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells
- (2012) Tomohisa Horibe et al. Molecular Cancer
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances
- (2012) P Muller et al. ONCOGENE
- Silencing Prion Protein in MDA-MB-435 Breast Cancer Cells Leads to Pleiotropic Cellular Responses to Cytotoxic Stimuli
- (2012) Guohua Yu et al. PLoS One
- Secreted Stress-Induced Phosphoprotein 1 Activates the ALK2-SMAD Signaling Pathways and Promotes Cell Proliferation of Ovarian Cancer Cells
- (2012) Chia-Lung Tsai et al. Cell Reports
- Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells
- (2011) Giulia Barbieri et al. Autophagy
- RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation
- (2011) Naomi Walsh et al. CANCER LETTERS
- TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells
- (2011) Dongxiao Zhuang et al. INTERNATIONAL JOURNAL OF CANCER
- Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
- (2011) Tomohisa Horibe et al. Journal of Translational Medicine
- A Compound That Inhibits the HOP–Hsp90 Complex Formation and Has Unique Killing Effects in Breast Cancer Cell Lines
- (2011) Genaro Pimienta et al. MOLECULAR PHARMACEUTICS
- The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
- (2011) Manfred Westphal et al. NATURE REVIEWS NEUROSCIENCE
- Standard of care therapy for malignant glioma and its effect on tumor and stromal cells
- (2011) T S Jones et al. ONCOGENE
- Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion
- (2011) Jessica D. Sims et al. PLoS One
- Enhanced Neural Progenitor/Stem Cells Self-Renewal via the Interaction of Stress-Inducible Protein 1 with the Prion Protein
- (2011) Tiago G. Santos et al. STEM CELLS
- Cellular prion protein promotes glucose uptake through the Fyn-HIF-2α-Glut1 pathway to support colorectal cancer cell survival
- (2010) Qing-Quan Li et al. CANCER SCIENCE
- Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma
- (2010) Hiroshi Kubota et al. CELL STRESS & CHAPERONES
- Pro-prion Binds Filamin A, Facilitating Its Interaction with Integrin β1, and Contributes to Melanomagenesis
- (2010) Chaoyang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stress-induced Phosphoprotein 1 as a Secreted Biomarker for Human Ovarian Cancer Promotes Cancer Cell Proliferation
- (2010) Tzu-Hao Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Novel Medical Therapeutics in Glioblastomas, Including Targeted Molecular Therapies, Current and Future Clinical Trials
- (2010) Eudocia C. Quant et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- NAViGaTOR: Network Analysis, Visualization and Graphing Toronto
- (2009) Kevin R. Brown et al. BIOINFORMATICS
- Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer
- (2009) Chaoyang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of pancreatic cancer invasion-related proteins by proteomic analysis
- (2009) Naomi Walsh et al. Proteome Science
- Interventions for cognitive deficits in adults with brain tumours
- (2008) Karin Gehring et al. LANCET NEUROLOGY
- Physiology of the Prion Protein
- (2008) Rafael Linden et al. PHYSIOLOGICAL REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started